Evidence map›Paper›PMID 36933624›Full record

ArticleGastroenterology2023

Is the Quantification of Interstitial Cells of Cajal in Gastric Biopsy Samples in Patients With Gastroparesis Ready for Prime Time?

Michael Camilleri, Jan Tack

Abstract readComment
In one paragraph

Article in Gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Michael CamilleriDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Jan TackDivision of Gastroenterology and Hepatology, Leuven University Hospitals, Leuven, Belgium.

Funding

A randomized control trial of G-POEM for gastroparesis to assess feasibility, safety, efficacy and physiological mechanismsR01DK125680 · NIDDK · MAYO CLINIC ARIZONA · PI CAMILLERI, MICHAEL L., PASRICHA, PANKAJ J · 2021 to 2024
$2.2M
Pharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Cannabidiol for Gastroparesis and Functional DyspepsiaR01DK122280 · NIDDK · MAYO CLINIC ROCHESTER · PI CAMILLERI, MICHAEL L. · 2019 to 2022
$1.5M
NIDDK NIH HHS R01 DK122280NIDDK NIH HHS R01 DK125680
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GastroparesisInterstitial Cells of CajalBiopsyGastric EmptyingHumans

Identifiers

PMID36933624
PMCPMC10293073

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.